BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38342418)

  • 1. Deubiquitinase OTUD6a drives cardiac inflammation and hypertrophy by deubiquitination of STING.
    Fang Z; Han J; Lin L; Ye B; Qu X; Zhang Y; Zhao Y; Xu D; Lin W; Shen S; Min J; Wu G; Huang Z; Liang G
    Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167061. PubMed ID: 38342418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STING activation in cardiomyocytes drives hypertrophy-associated heart failure via NF-κB-mediated inflammatory response.
    Wang L; Zhang S; Liu H; Gao L; He L; Chen Y; Zhang J; Yang M; He C
    Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):166997. PubMed ID: 38142758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes.
    Ye B; Zhou H; Chen Y; Luo W; Lin W; Zhao Y; Han J; Han X; Huang W; Wu G; Wang X; Liang G
    Circ Res; 2023 Feb; 132(4):465-480. PubMed ID: 36722348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OTUD1 promotes pathological cardiac remodeling and heart failure by targeting STAT3 in cardiomyocytes.
    Wang M; Han X; Yu T; Wang M; Luo W; Zou C; Li X; Li G; Wu G; Wang Y; Liang G
    Theranostics; 2023; 13(7):2263-2280. PubMed ID: 37153745
    [No Abstract]   [Full Text] [Related]  

  • 5. Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3.
    Liu X; Fang Y; Lv X; Hu C; Chen G; Zhang L; Jin B; Huang L; Luo W; Liang G; Wang Y
    Cell Death Differ; 2023 Jun; 30(6):1457-1471. PubMed ID: 36932155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistance.
    Cui J; Liu X; Shang Q; Sun S; Chen S; Dong J; Zhu Y; Liu L; Xia Y; Wang Y; Xiang L; Fan B; Zhan J; Zhou Y; Chen P; Zhao R; Liu X; Xing N; Wu D; Shi B; Zou Y
    Mol Cancer; 2024 Apr; 23(1):86. PubMed ID: 38685067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian tumor deubiquitinase 6A regulates cell proliferation via deubiquitination of nucleolin and caspase‑7.
    Kim SH; Baek KH
    Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 36082810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STING is an essential regulator of heart inflammation and fibrosis in mice with pathological cardiac hypertrophy via endoplasmic reticulum (ER) stress.
    Zhang Y; Chen W; Wang Y
    Biomed Pharmacother; 2020 May; 125():110022. PubMed ID: 32106379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OTUD6A in tubular epithelial cells mediates angiotensin II-induced kidney injury by targeting STAT3.
    Sun X; Chen S; Zhao Y; Wu T; Zhao Z; Luo W; Han J; Fang Z; Ye B; Cao G; Huang S; Liang G
    Am J Physiol Cell Physiol; 2024 Feb; 326(2):C400-C413. PubMed ID: 38105755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De-ubiquitination of p300 by USP12 Critically Enhances METTL3 Expression and Ang II-induced cardiac hypertrophy.
    Lu P; Xu Y; Sheng ZY; Peng XG; Zhang JJ; Wu QH; Wu YQ; Cheng XS; Zhu K
    Exp Cell Res; 2021 Sep; 406(1):112761. PubMed ID: 34339675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting E3 Ubiquitin Ligase WWP1 Prevents Cardiac Hypertrophy Through Destabilizing DVL2 via Inhibition of K27-Linked Ubiquitination.
    Zhao D; Zhong G; Li J; Pan J; Zhao Y; Song H; Sun W; Jin X; Li Y; Du R; Nie J; Liu T; Zheng J; Jia Y; Liu Z; Liu W; Yuan X; Liu Z; Song J; Kan G; Li Y; Liu C; Gao X; Xing W; Chang YZ; Li Y; Ling S
    Circulation; 2021 Aug; 144(9):694-711. PubMed ID: 34139860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSDMD (Gasdermin D) Mediates Pathological Cardiac Hypertrophy and Generates a Feed-Forward Amplification Cascade via Mitochondria-STING (Stimulator of Interferon Genes) Axis.
    Han J; Dai S; Zhong L; Shi X; Fan X; Zhong X; Lin W; Su L; Lin S; Han B; Xu J; Hong X; Huang W; Ye B
    Hypertension; 2022 Nov; 79(11):2505-2518. PubMed ID: 36065823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OTUD6A Is an Aurora Kinase A-Specific Deubiquitinase.
    Kim HJ; Kim J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deubiquitinase Inhibitor Auranofin Attenuated Cardiac Hypertrophy by Blocking NF-κB Activation.
    Hu M; Zhang Z; Liu B; Zhang S; Chai R; Chen X; Kong T; Zhang F; Zhang J; Liu S; Liu N
    Cell Physiol Biochem; 2018; 45(6):2421-2430. PubMed ID: 29554646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deubiquitinase OTUD6A Regulates Innate Immune Response via Targeting UBC13.
    Li Z; Li G; Li Y; Luo Y; Jiang Y; Zhang Z; Zhou Z; Liu S; Wu C; You F
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac-specific BACH1 ablation attenuates pathological cardiac hypertrophy by inhibiting the Ang II type 1 receptor expression and the Ca2+/CaMKII pathway.
    Wei X; Jin J; Wu J; He Y; Guo J; Yang Z; Chen L; Hu K; Li L; Jia M; Li Q; Lv X; Ge F; Ma S; Wu H; Zhi X; Wang X; Jiang L; Osto E; Zhang J; Meng D
    Cardiovasc Res; 2023 Aug; 119(9):1842-1855. PubMed ID: 37279500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STING protects against cardiac dysfunction and remodelling by blocking autophagy.
    Xiong R; Li N; Chen L; Wang W; Wang B; Jiang W; Geng Q
    Cell Commun Signal; 2021 Nov; 19(1):109. PubMed ID: 34749750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OTUD6A promotes prostate tumorigenesis via deubiquitinating Brg1 and AR.
    Fu X; Zhao J; Yu G; Zhang X; Sun J; Li L; Yin J; Niu Y; Ren S; Zhu Y; Xu B; Huang L
    Commun Biol; 2022 Mar; 5(1):182. PubMed ID: 35233061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure.
    Beak JY; Kang HS; Huang W; Myers PH; Bowles DE; Jetten AM; Jensen BC
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H186-H200. PubMed ID: 30387679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
    Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
    J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.